GCTK
GlucoTrack Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
integrity applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. since its founding in 2001, integrity applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. integrity applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. after proof of concept in 2002, integrity applications developed the first working prototype, glucotrack in august 2003. glucotrack® model df-f received ce mark approval in june 2013 and kfda in march 2016. glucotrack is currently being marketed in the european union and in south korea. the company went public in november 2011 and is
Market Cap: 6.48 Million
Primary Exchange: NASDAQ
Website: http://www.integrity-app.com/
Shares Outstanding: 20.9 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 2.2159519420693465
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Ethical Flags
Longest drawdown: 597 trading days
From: 2022-03-31 To: 2024-03-07
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|